Bruce Conklin, MD, introduces you to CRISPR, a disruptive technology influencing advances in treatment and cures of diseases through gene editing. Conklin walks you through how CRISPR works before diving into its evolution in his lab at Gladstone, using application examples such as treating cancer, curing Alzheimer’s, and testing drug therapies to prevent cardiac damage in COVID-19 patients. You’ll also hear about this DNA-editing technology’s bright future expanding its reach into cures for more diseases.
Support Our COVID-19 Research Efforts
Gladstone scientists are moving quickly to respond to the coronavirus outbreak. Help us end this pandemic.
World’s Largest Public ALS Data Portal Launched
Article
April 13, 2021
World’s Largest Public ALS Data Portal Launched
Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.
Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCsLeading the Way to Better Treatments for People with Epilepsy
Article
March 26, 2021
Leading the Way to Better Treatments for People with Epilepsy
Gladstone researchers harness unique tools and perspectives to study life-threatening seizures that lack a cure
Gladstone Experts Epilepsy Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab Mucke Lab Palop Lab Paz LabA Disease Is Only Rare until It Messes with the Wrong Mother
Article
February 18, 2021
A Disease Is Only Rare until It Messes with the Wrong Mother
Amber Freed is racing against the clock to cure her son from a rare neurological condition
Donor Stories Gladstone Experts Epilepsy Neurological Disease Paz Lab